Waraich* Ahad, Clemons Channing, Ramirez Roma, Yih Jessica, Goldstein Sue, and Goldstein Irwin, “Mp78-15 post-ssri sexual dysfunction (pssd): ten year retrospective chart review,” Journal of Urology , vol. 203, no. Supplement 4, pp. e1179–e1179, Apr. 2020
This series of PSSD patients examined clinically is larger than any in the peer-reviewed literature. Consistent with other reports on PSSD, our patients are young, have ED in most cases, and frequently have concomitant HSDD, poor orgasm and decreased genital sensation. New information includes the facts that 1) ED is most often severe, 2) erectile tissue inhomogeneity is common, consistent with erectile tissue fibrosis/decreased erectile tissue expandability as an underlying vascular ED pathophysiology, and 3) decreased genital sensation from neurological dysfunction is frequent in this population. Providers need to be aware that the persistent sexual health consequences following SSRI/SNRI discontinuation are significant and patients should be referred to sexual medicine specialists for management
A crucial recognition of the existence of PSSD published in the journal of the American Urological Association showing physical signs of ED and noting sensory dysfunction and low libido as aspects of PSSD. Unfortunately, no mention of anhedonia, fatigue, or other common non-sexual symptoms among PSSD patients.
These appear to be patients of Dr. Irwin Goldstein’s clinic.